David A Harris

Title: David A. Harris: Innovator in Neurodegenerative Disorder Treatments

Introduction

David A. Harris is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of neurodegenerative disorders through his innovative research and patent. His work focuses on therapeutic agents that target prion proteins, which are implicated in various neurodegenerative diseases.

Latest Patents

David A. Harris holds a patent for "Prion protein ligands as therapeutic agents for neurodegenerative disorders." This invention provides compositions and methods for the treatment of neurodegenerative diseases, particularly those associated with protein aggregation. The patent is based on the discovery of binding regions on the surface of PrPc, known as PrPc Binding Domains (PBD). The inventor has identified six distinct binding regions on PrPc, referred to as PBD-1 through PBD-6. These domains are defined by clusters of amino acids located in the globular domain of the protein, specifically in the C-terminal half of the protein, which includes residues 120-230. One embodiment of the invention utilizes residues 127-226.

Career Highlights

Throughout his career, David A. Harris has worked with prestigious institutions, including Boston University and Università di Perugia. His research has focused on understanding the mechanisms of neurodegenerative diseases and developing innovative therapeutic strategies.

Collaborations

David has collaborated with notable colleagues such as Emiliano Biasini and Aaron Beaty Beeler. Their combined expertise has contributed to advancements in the understanding and treatment of neurodegenerative disorders.

Conclusion

David A. Harris is a pioneering inventor whose work in neurodegenerative disorders has the potential to lead to significant advancements in therapeutic treatments. His innovative approach to targeting prion proteins showcases the importance of research in developing effective solutions for complex medical challenges.